Charles River Laboratories International, Inc.(CRL US)
$345.37+5.711.68%Ext:$348.72+3.350.97%(Market Closed · 00:00:05 UTC)
- Pricing and plans
Get the full experience
We save the real magic for signed-in users.
Get the full experience
We save the real magic for signed-in users.
| Millions USD (ex. Per Share) | FY199812/31/1998 | FY199912/31/1999 | FY200012/31/2000 | FY200112/31/2001 | FY200212/31/2002 | FY200312/31/2003 | FY200412/31/2004 | FY200512/31/2005 | FY200612/31/2006 | FY200712/31/2007 | FY200812/31/2008 | FY200912/31/2009 | FY201012/31/2010 | FY201112/31/2011 | FY201212/31/2012 | FY201312/31/2013 | FY201412/31/2014 | FY201512/31/2015 | FY201612/31/2016 | FY201712/31/2017 | FY201812/31/2018 | FY201912/31/2019 | FY202012/31/2020 | FY202112/31/2021 | FY202212/31/2022 | FY202312/31/2023 | FY202412/28/2024 | FY202512/27/2025 | Last 12M03/28/2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | 276.8 | 194.6 | 213.8 | 191.8 | |||||||||||||||||||||||||||
| Short Term Investments | - | - | - | - | |||||||||||||||||||||||||||
| Cash and Short Term Investments | 276.8 | 194.6 | 213.8 | 191.8 | |||||||||||||||||||||||||||
| Net Receivables | 780.4 | 720.9 | 708.9 | 700.3 | |||||||||||||||||||||||||||
| Inventory | 380.3 | 278.5 | 299.1 | 359.7 | |||||||||||||||||||||||||||
| Other Current Assets | 83.4 | 105.8 | 8.6 | 134.9 | |||||||||||||||||||||||||||
| Total Current Assets | 1,608.7 | 1,403.1 | 1,447.0 | 1,488.8 | |||||||||||||||||||||||||||
| Property, Plant & Equipment | 2,033.8 | 2,016.5 | 2,016.6 | 1,828.0 | |||||||||||||||||||||||||||
| Long Term Investments | 243.8 | 218.4 | 207.0 | 209.7 | |||||||||||||||||||||||||||
| Other Non-Current Assets | 309.4 | 278.2 | 293.2 | 826.2 | |||||||||||||||||||||||||||
| Total Non-Current Assets | 6,586.3 | 6,125.3 | 5,688.4 | 6,241.5 | |||||||||||||||||||||||||||
| Total Assets | 8,195.0 | 7,528.3 | 7,135.4 | 7,730.3 | |||||||||||||||||||||||||||
| Account Payables | 168.9 | 140.3 | 148.8 | 134.0 | |||||||||||||||||||||||||||
| Short Term Debt | - | - | 61.1 | - | |||||||||||||||||||||||||||
| Deferred Revenue | 241.8 | 248.3 | 210.4 | 194.3 | |||||||||||||||||||||||||||
| Other Current Liabilities | 431.0 | 373.4 | 392.2 | 393.0 | |||||||||||||||||||||||||||
| Total Current Liabilities | 1,055.1 | 994.1 | 1,120.3 | 1,093.7 | |||||||||||||||||||||||||||
| Long Term Debt | 2,647.1 | 2,240.2 | 2,545.8 | 2,663.1 | |||||||||||||||||||||||||||
| Other Non-Current Liabilities | 223.2 | 195.2 | -341.4 | 510.6 | |||||||||||||||||||||||||||
| Total Non-Current Liabilities | 3,480.9 | 3,026.2 | 2,803.9 | 3,648.3 | |||||||||||||||||||||||||||
| Total Liabilities | 4,536.0 | 4,020.3 | 3,924.2 | 4,742.0 | |||||||||||||||||||||||||||
| Common Stock | 0.5 | 0.5 | 0.5 | 0.5 | |||||||||||||||||||||||||||
| Retained Earnings | 1,887.2 | 1,812.1 | 1,388.6 | 1,373.8 | |||||||||||||||||||||||||||
| Total Stockholders Equity | 3,596.9 | 3,461.5 | 3,164.6 | 2,940.6 | |||||||||||||||||||||||||||
| Total Liabilities and Equity | 8,195.0 | 7,528.3 | 7,135.4 | 7,730.3 | |||||||||||||||||||||||||||